Generation and application of patient-derived xenograft models in pancreatic cancer research

por Wang, Cheng-Fang, Shi, Xian-Jie
Publicado 2019

Sirolimus increases the anti-cancer effect of Huai Er by regulating hypoxia inducible factor-1α-mediated glycolysis in hepatocellular carcinoma

por Zhou, Lin, Zhao, Yang, Pan, Li-Chao, Wang, Jing, Shi, Xian-Jie, Du, Guo-Sheng, He, Qiang
Publicado 2022

PD-L1(+)NEUT, Foxp3(+)Treg, and NLR as New Prognostic Marker with Low Survival Benefits Value in Hepatocellular Carcinoma

por Zhou, Lin, Wang, Jing, Lyu, Shao-cheng, Pan, Li-chao, Shi, Xian-jie, Du, Guo-sheng, He, Qiang
Publicado 2021

Clinicopathological Characteristics and Prognostic Factors of Intrahepatic Biliary Cystadenocarcinoma

por Xu, Ming-Yue, Shi, Xian-Jie, Wan, Tao, Liang, Yu-Rong, Wang, Hong-Guang, Zhang, Wen-Zhi, He, Lei, Chen, Ming-Yi, Lyu, Shao-Cheng, Zhang, Wen-Wen, Li, Hui-Xing
Publicado 2015

Sirolimus treatment for cirrhosis or hepatocellular carcinoma patients accompanied by psoriasis after liver transplantation: A single center experience

por Zhou, Lin, Du, Guo-Sheng, Pan, Li-Chao, Zheng, Yong-Gen, Liu, Zhi-Jia, Shi, Hai-Da, Yang, Shao-Zhen, Shi, Xian-Jie, Xuan, Meng, Feng, Li-Kui, Zhu, Zhi-Dong
Publicado 2017